XTANT Financial Statements From 2010 to 2024
| XMS Stock | EUR 0.34 0.01 3.03% |
Check XTANT MEDICAL financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among XTANT MEDICAL's main balance sheet or income statement drivers, such as , as well as many indicators such as . XTANT financial statements analysis is a perfect complement when working with XTANT MEDICAL Valuation or Volatility modules.
XTANT |
XTANT MEDICAL HLDGS Company Shares Owned By Insiders Analysis
XTANT MEDICAL's Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Current XTANT MEDICAL Shares Owned By Insiders | 7.59 % |
Most of XTANT MEDICAL's fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, XTANT MEDICAL HLDGS is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
| Competition |
Based on the latest financial disclosure, 7.59% of XTANT MEDICAL HLDGS are shares owned by insiders. This is 50.0% lower than that of the Healthcare sector and 51.19% lower than that of the Medical Devices industry. The shares owned by insiders for all Germany stocks is 24.78% higher than that of the company.
XTANT MEDICAL HLDGS Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining XTANT MEDICAL's current stock value. Our valuation model uses many indicators to compare XTANT MEDICAL value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across XTANT MEDICAL competition to find correlations between indicators driving XTANT MEDICAL's intrinsic value. More Info.XTANT MEDICAL HLDGS is rated first in return on equity category among its peers. It is rated first in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the XTANT MEDICAL's earnings, one of the primary drivers of an investment's value.About XTANT MEDICAL Financial Statements
XTANT MEDICAL stakeholders use historical fundamental indicators, such as XTANT MEDICAL's revenue or net income, to determine how well the company is positioned to perform in the future. Although XTANT MEDICAL investors may analyze each financial statement separately, they are all interrelated. For example, changes in XTANT MEDICAL's assets and liabilities are reflected in the revenues and expenses on XTANT MEDICAL's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in XTANT MEDICAL HLDGS. Please read more on our technical analysis and fundamental analysis pages.
Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. Xtant Medical Holdings, Inc. is headquartered in Belgrade, Montana. XTANT MEDICAL operates under Medical Devices classification in Germany and is traded on Frankfurt Stock Exchange. It employs 110 people.
Currently Active Assets on Macroaxis
Other Information on Investing in XTANT Stock
XTANT MEDICAL financial ratios help investors to determine whether XTANT Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in XTANT with respect to the benefits of owning XTANT MEDICAL security.